WHO ICTRP trial
NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS
CTIS2024-519405-35-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-519405-35-00 |
|---|---|
| Public title | NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS |
| Scientific title | NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS |
| Primary sponsor | Mimetech S.r.l. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Italy |
| Conditions | Diabetic Foot Ulcer MedDRA version: 24.0Level: LLTClassification code: 10012664Term: Diabetic foot ulcer Class: 10040785;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] |
| Interventions | Product Name: Udonitrectag, Product Code:PRD9223558, Pharmaceutical Form: SOLUTION FOR EXTERNAL USE, Other descriptive name: , Strength: |
| Registration date | Sep 12, 2024 |
| Target size | 24 |
| Secondary IDs | 2021-002212-31 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: